Learn More
Apexbio Technology LLC Odanacatib (MK-0822) 603139-19-1 5mg

Supplier: Apexbio Technology LLC A24875

Odanacatib (MK-0822 CAS 603139-19-1) is a potent orally bioavailable and selective inhibitor of cathepsin K exhibiting an IC50 of 0 2 nM Cathepsin K is predominantly expressed in osteoclasts where it plays an essential role in the degradation of bone collagen matrix and bone resorption By inhibiting cathepsin K odanacatib suppresses bone resorption while partially preserving bone formation as demonstrated in both preclinical studies and phase IIb clinical trials in postmenopausal women Odanacatib is under investigation for its potential to reduce fracture risk in osteoporosis research
The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.